Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Johnson

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2016
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular CarcinomaJulien Edeline, Jean-Frédéric Blanc, Philip Johnson, et al.
The Lancet. HIV|March 20, 2019
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trialFrances H Priddy, David J M Lewis, Huub C Gelderblom, et al.
IUBMB Life|July 18, 2002
Alphavirus replicon particles as candidate HIV vaccinesNancy L Davis, Ande West, Elizabeth Reap, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infectionHamish Innes, Peter Jepsen, Scott McDonald, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 21, 2018
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selectionCharing C N Chong, Kit-Fai Lee, Cheuk-Man Chu, et al.
The Lancet. Gastroenterology & Hepatology|April 11, 2018
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trialMasatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka, et al.
Cardiovascular and Interventional Radiology|February 28, 2023
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular CarcinomaCristina Mosconi, Joanne O'Rourke, Roman Kloeckner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environmentAlessandro Cucchetti, Annagiulia Gramenzi, Philip Johnson, et al.
Journal of Veterinary Internal Medicine|December 7, 2018
Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018)Joy E Tomlinson, Amit Kapoor, Arvind Kumar, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2016
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular CarcinomaJulien Edeline, Jean-Frédéric Blanc, Philip Johnson, et al.
The Lancet. HIV|March 20, 2019
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trialFrances H Priddy, David J M Lewis, Huub C Gelderblom, et al.
IUBMB Life|July 18, 2002
Alphavirus replicon particles as candidate HIV vaccinesNancy L Davis, Ande West, Elizabeth Reap, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infectionHamish Innes, Peter Jepsen, Scott McDonald, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 21, 2018
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selectionCharing C N Chong, Kit-Fai Lee, Cheuk-Man Chu, et al.
The Lancet. Gastroenterology & Hepatology|April 11, 2018
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trialMasatoshi Kudo, Kazuomi Ueshima, Osamu Yokosuka, et al.
Cardiovascular and Interventional Radiology|February 28, 2023
Textbook Outcome After Trans-arterial Chemoembolization for Hepatocellular CarcinomaCristina Mosconi, Joanne O'Rourke, Roman Kloeckner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 18, 2016
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in PatientsSarah Berhane, Hidenori Toyoda, Toshifumi Tada, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environmentAlessandro Cucchetti, Annagiulia Gramenzi, Philip Johnson, et al.
Journal of Veterinary Internal Medicine|December 7, 2018
Viral testing of 18 consecutive cases of equine serum hepatitis: A prospective study (2014-2018)Joy E Tomlinson, Amit Kapoor, Arvind Kumar, et al.
Pageof 10